Skip to main content
Tech.euFundingExplorerBeta

AstriVax

KU Leuven spin-off that develops vaccines

Total raised
€33M
€32,500,000
Funding rounds
2
Investors
9
distinct backers
Active since
2022-08
latest 2023-05

Funding by year

EUR raised per year

Signals

High confidence
Raise-next likelihood14
base rate 45% for Grant
  • Dormant (no round in 3+ cohort gaps)
  • Down/flat last round
  • Low backer re-investment
Exit likelihood14
base rate 12% (2+ rounds)
  • €30M+ raised

Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Related news

Similar companies

same sector or country